RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Myriad Genetics Incorporated

A collection of news and information related to Myriad Genetics Incorporated published by this site and its partners.

Top Myriad Genetics Incorporated Articles see all

Displaying items 1-5
  • Genes are complex; gene patents might be more so

     
    Genetic research breakthroughs have come to be expected -- greeted with a sense of inevitability and the quiet assurance that science will ultimately puzzle out, then cure, human disease. But how those breakthroughs actually yield benefits is complicated. An e
  • Gene patent case could impact patients, research

    Gene patent case could impact patients, research
    Every time a woman is tested for gene mutations linked to significantly higher rates of breast and ovarian cancer, her blood is sent to a lab in Utah. That's because Salt Lake City-based Myriad Genetics Inc. owns the patents to the BRCA 1 and BRCA 2...

    23andMe's designer baby patent is 'a serious mistake,' critics charge

    23andMe's designer baby patent is 'a serious mistake,' critics charge
    What’s even more repulsive than the idea of using DNA tests to help people create a designer babies? Getting a patent for the idea. 23andMe, the pioneering direct-to-consumer genetic testing company, was awarded such a patent in September. U.S....

    Genetic cancer test often urged for wrong women

    Genetic cancer test often urged for wrong women
    NEW YORK (Reuters) - Doctors are too quick to recommend expensive genetic counseling or testing for ovarian cancer, but at the same time often fail to refer women at high risk for the disease, government researchers said. Ovarian cancer isn't very common...

    Researchers hail Supreme Court decision on gene patent

    Researchers hail Supreme Court decision on gene patent
    The U.S. Supreme Court decision that Myriad Genetics cannot patent two genes linked to ovarian and breast cancer came as welcome relief to researchers whose work on BRCA1 and BRCA2 genes had been thwarted by legal challenges from the company. But...